A detailed history of Jane Street Group, LLC transactions in Rallybio Corp stock. As of the latest transaction made, Jane Street Group, LLC holds 22,275 shares of RLYB stock, worth $22,052. This represents 0.0% of its overall portfolio holdings.

Number of Shares
22,275
Previous 53,080 58.04%
Holding current value
$22,052
Previous $71,000 63.38%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$1.09 - $1.45 $33,577 - $44,667
-30,805 Reduced 58.04%
22,275 $26,000
Q2 2024

Aug 14, 2024

BUY
$1.34 - $2.98 $71,127 - $158,178
53,080 New
53,080 $71,000
Q4 2023

Feb 14, 2024

BUY
$1.91 - $4.39 $47,213 - $108,516
24,719 New
24,719 $59,000

Others Institutions Holding RLYB

About Rallybio Corp


  • Ticker RLYB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,132,000
  • Market Cap $31.8M
  • Description
  • Rallybio Corporation, a clinical-stage biotechnology company, engages in discovering, developing, manufacturing, and delivering therapies that enhance the lives of patients suffering from severe and rare diseases. Its lead product candidate is RLYB212, a monoclonal anti-HPA-1a antibody that is in Phase I clinical trial for the prevention of feta...
More about RLYB
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.